The Effect of a Clinical Pathway on Reducing the Rate of Healthcare-Onset Clostridioides difficile

INTRODUCTION: Stool assays used to diagnose Clostridioides difficile infection (CDI) do not differentiate acute CDI from asymptomatic carriers, which contributes to a falsely elevated rate of healthcare-facility onset (HO) CDI when CD stool assays are inappropriately ordered. The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Millard, John W., Agha, Yasmine Hussein, Srinivasan, Sachin, Assi, Maha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Kansas Medical Center 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651785/
https://www.ncbi.nlm.nih.gov/pubmed/33173561
http://dx.doi.org/10.17161/kjm.vol13.14762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651785/
https://www.ncbi.nlm.nih.gov/pubmed/33173561
http://dx.doi.org/10.17161/kjm.vol13.14762

Ejemplares similares